Live Deal Pipeline
Deal detail
Browse Samjong KPMG's control sale, investment, and real-estate opportunities in one place.
Healthcare & BiotechPublished deal
Project Synergy - Financing
Health-supplement OEM and ODM with facilities and know-how supporting a wide range of dosage forms, functions, and packaging formats
| Location | Korea |
|---|---|
| Industry | Healthcare & Biotech |
| Revenue | KRW 10B-50B |
| Asking | KRW 12 billion on a 100% equity basis (negotiable) |
| Deal structure | Capital raise; structure open to discussion |
| Financials | 2025 revenue of KRW 18.7 billion and EBITDA of KRW 1.2 billion |
Investment highlights
- Stable revenue pipeline and production efficiency supported by a high-quality customer base
- Turnaround through productivity gains and cost-efficiency measures
- Positioned to benefit from sustained health-supplement demand growth and government-led market-development policies
Deal partner
Hyerim Oh, Manager